Tuberculosis treatment coverage in Iran
Iran: Tuberculosis treatment coverage was 73 in 2024. ▲ Rising
Tuberculosis treatment coverage in Iran, 2000–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for tuberculosis treatment coverage in Iran is 73, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 21.7% over ten years.
Over the whole period, tuberculosis treatment coverage in Iran peaked at 73 in 2023 and was at its lowest, 41, in 2000.
That places Iran 107th out of 194 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Tuberculosis treatment coverage in Iran, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 41 | — |
| 2001 | 42 | +2.4% |
| 2002 | 42 | +0.0% |
| 2003 | 42 | +0.0% |
| 2004 | 42 | +0.0% |
| 2005 | 42 | +0.0% |
| 2006 | 43 | +2.4% |
| 2007 | 44 | +2.3% |
| 2008 | 45 | +2.3% |
| 2009 | 46 | +2.2% |
| 2010 | 47 | +2.2% |
| 2011 | 50 | +6.4% |
| 2012 | 53 | +6.0% |
| 2013 | 56 | +5.7% |
| 2014 | 60 | +7.1% |
| 2015 | 63 | +5.0% |
| 2016 | 66 | +4.8% |
| 2017 | 68 | +3.0% |
| 2018 | 70 | +2.9% |
| 2019 | 72 | +2.9% |
| 2020 | 53 | -26.4% |
| 2021 | 57 | +7.5% |
| 2022 | 69 | +21.1% |
| 2023 | 73 | +5.8% |
| 2024 | 73 | +0.0% |
Iran compared with similar countries
- Iran's 73 is below the median for upper middle income countries, which is 74, 99% of the median. (57 countries reporting)
- Iran's 73 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 73, 1.0× the median. (23 countries reporting)
Biggest year-on-year movements
Years where Tuberculosis treatment coverage in Iran changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2020 | -26.4% | 72 | 53 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.9 | 41 | 46 | 10 |
| 2010s | 60.5 | 47 | 72 | 10 |
| 2020s | 65 | 53 | 73 | 5 |
Countries ranked near Iran
More health data for Iran
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0311 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is tuberculosis treatment coverage in Iran?
- Tuberculosis treatment coverage in Iran was 73 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest tuberculosis treatment coverage recorded in Iran?
- The highest recorded value was 73 in 2023.
- What is the lowest tuberculosis treatment coverage recorded in Iran?
- The lowest recorded value was 41 in 2000.
- How does Iran rank for tuberculosis treatment coverage?
- Iran ranks 107th out of 194 countries with data for 2024.
- Is tuberculosis treatment coverage rising or falling in Iran?
- Over the last ten years it is up 21.7%. The long-run trend across the full record is rising.
- Where does this Iran data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Tuberculosis treatment coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).